Ayanda

What Ayanda does

SIRIO Europe (legally Sirio Europe GmbH & Co. KG, operating its German manufacturing facility under the Ayanda brand) is a privately held contract development and manufacturing organization (CDMO) that develops and produces nutraceutical and pharmaceutical dosage forms on behalf of brand customers. The company is headquartered at its primary European manufacturing site in Pritzwalk, Germany, with additional registered offices in Frankfurt am Main and production facilities in Shantou and Anhui (China) and the USA; the broader SIRIO Group employs more than 2,700 people across China, Germany, the USA, Singapore and Thailand. Its customer base consists of nutraceutical brands, pharmaceutical companies, sports-nutrition brands and beauty/wellness labels that buy contract-manufactured products and private-label concepts.

The product portfolio is anchored on four core delivery formats — gummies (including high-strength XtraGummies™), softgels (gelatin and plant-based Plantegrity®), LifeChews™ chewable jelly tablets and FizzyBits™ instant dissolving tablets — supported by the Snowmelt™ direct-to-mouth powder format and trademarked sub-brands including EnteriClear®, HydraPearls™ and Aeion™. Proprietary technology is a key differentiator: Plantegrity® covers four patented plant-based shell variants including an enteric gellan-gum shell; LifeChews™ is clinically validated for 161% higher plasma DHA concentration versus control; and XtraGummies™ enables up to 1.5g of creatine per gummy. Branded concept platforms bundle these formats into ready-to-launch ranges (Aeion™ longevity, X Mg magnesium, Hydration Reinvented), giving brand customers a faster path to market than custom formulation alone.

The business model is B2B contract manufacturing with quote-based pricing, minimum order quantities starting at 500,000 units and multi-year contracts; the go-to-market is enterprise field sales organised by region (DACH, South Europe, EMEA, Key Accounts, Retail/Pharmacy Chains), supported by major trade-show presence at Vitafoods Europe and CPHI, proprietary Innovation for the Future Summits, and thought-leadership content (podcast, webinars, downloadable catalogues). Revenue is not publicly disclosed. Quality and compliance are positioned as a primary asset: SIRIO holds GMP, BRCGS, IFS, FDA, MSC Chain of Custody, Organic, Friend of the Sea and ISO 14001/50001/45001/14064 certifications, plus EcoVadis Silver with dual-facility ranking in the global top 15%, making it an approved supplier for regulated retail and pharmacy channels in both the EU and the US.

Name

Ayanda

Legal name

Sirio Europe GmbH & Co. KG

Website

https://ayanda.com

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

501–1,000 employees

Short description

SIRIO Europe (operating as Ayanda) is a privately held B2B contract development and manufacturing organization (CDMO) that produces nutraceutical softgels, gummies, and proprietary delivery formats for brand customers in the nutraceutical, pharmaceutical, sports nutrition and beauty/wellness sectors globally.

Ownership category

akta.pro rank

Headquarters

HQ city

Oslo

HQ country

Norway

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Contract Development and Manufacturing Services: Full-service CDMO providing end-to-end development, manufacturing, and packaging services for dietary supplements and pharmaceutical softgels. Revenue generated through service fees, manufacturing contracts, and project-based development work for B2B clients.
2. Private Label Manufacturing: Private label production of ready-to-launch formulations including gummies, softgels, and innovative delivery formats. Clients can select from pre-developed concepts or commission custom formulations.
3. Product Sales (Bulk Manufacturing): Bulk manufacturing of supplement products for B2B customers including nutraceutical companies, pharmaceutical firms, and brand owners. Minimum order quantities starting at 500,000 units for typical production runs.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

SIRIO Europe (operating under the Ayanda brand) is a B2B Contract Development and Manufacturing Organization (CDMO) that develops, manufactures, and packages dietary supplement dosage forms for nutraceutical and pharmaceutical brand clients. Its core deliverables include gummies, softgels (gelatine and plant-based), LifeChews™ jelly tablets, and FizzyBits™ instant fizzy tablets, supported by proprietary technologies such as Plantegrity® and EnteriClear®, plus ready-to-launch concept platforms spanning beauty, sports, women's health, hydration, magnesium, and longevity. Services span R&D, manufacturing, quality management, packaging, and private label production with minimum order quantities of 500,000+ units.

Product overview

Ayanda operates as a Contract Development and Manufacturing Organization (CDMO) providing end-to-end services for nutraceutical and pharmaceutical dosage forms. The product portfolio centers on four core delivery formats: Gummies (including XtraGummies™ high-strength variants), Softgels (gelatine and plant-based Plantegrity®), LifeChews™ jelly tablets, and FizzyBits™ instant fizzy tabs. These formats are supported by specialized technology platforms including Aeion™ longevity platform, X Mg magnesium platform, and Hydration Reinvented platform. Key sub-brands include EnteriClear® enteric technology, HydraPearls™ skin hydration softgels, and Snowmelt™ DTM powder. Services include development, manufacturing, quality management, and private label manufacturing across facilities in Europe, USA, and China.

Differentiator

Problem solved

Functional benefit

Brands

• Plantegrity®: Patented plant-based softgel technology using carrageenan or gellan gum for vegan-friendly capsule solutions.
• XtraGummies™
• FizzyBits™
• LifeChews™
• Aeion™
• Snowmelt™
• HydraPearls™
• EnteriClear®
• Aeion™ NAD+ Energy

Products and services

• Gummies

Quantifiable outcome

• 198% improvement in bioavailability with LifeChews™ vs control (161% higher blood plasma DHA concentration)
• +5 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Eleven partnerships are on record, tiered core and minor.

• ADMcoreStrategic or Co-development Partner · 22 May 2026ADM (Archer Daniels Midland) presented advances in probiotic and postbiotic ingredient science at the 7th Innovation for the Future Summit in Amsterdam. SIRIO collaborated with ADM on ingredient innovation and science-backed formulation approaches for the nutraceutical market.
• KD PharmacoreStrategic or Co-development Partner · 22 May 2026KD Pharma presented omega-3 innovation topics including 'Beyond Fish Oil: What's Next in Omega-3 Innovation' at SIRIO's Innovation for the Future Summit. Represents key ingredient supplier partnership for omega-3 formulations.
• Aker BioMarinecoreStrategic or Co-development Partner · 22 May 2026Aker BioMarine participated as speaker at SIRIO's Innovation for the Future Summit discussing omega-3 alternatives and solutions. Key supplier of premium, science-backed omega-3 products for SIRIO formulations.
• Zooca® (Calanus Company)minorStrategic or Co-development Partner · 22 May 2026Zooca® Calanus® Oil presented as innovative marine lipid ingredient at SIRIO's Innovation for the Future Summit. Represents sustainable omega-3 alternative ingredient sourced from Calanus finmarchicus.
• Balchem CorporationcoreStrategic or Co-development Partner · 22 May 2026Balchem presented 'Performance by design: The benefits behind sports ingredients' at Innovation for the Future Summit Berlin. Partnership focused on ingredient science and sports nutrition formulations.
• EHPM (European Federation of Associations of Health Product Manufacturers)coreGTM or Marketing Partner · 22 May 2026EHPM Director-General Livia Menichetti presented on key regulatory developments impacting supplements at the Innovation for the Future Summit Amsterdam. Partnership for regulatory intelligence and industry advocacy.
• Innova Market InsightscoreStrategic or Co-development Partner · 22 May 2026Innova Market Insights provided dietary supplements market and consumer trends analysis at both Amsterdam and Berlin Innovation Summits. Partnership for market intelligence and trend forecasting.
• Novasol (Aquanova)coreTechnology or Integration · 22 May 2026Aquanova/Novasol presented on bioavailability and why it determines performance at the Berlin Innovation Summit. Provider of NovaSOL® colloidal ingredient technology for enhanced absorption.
• GivaudanminorStrategic or Co-development PartnerGivaudan conducted flavor training sessions on evaluating samples at the Amsterdam Innovation Summit. Partnership for flavor development and sensory optimization of SIRIO formulations.
• Bureau VeritascoreTechnology or IntegrationThird-party verification partner for carbon inventories and emissions data across all manufacturing sites. Provides independent verification of sustainability metrics under ISO 14064:2018.
• SIRIO Institute on AgeingcoreStrategic or Co-development PartnerResearch collaboration for longevity platform development. Aeion™ longevity platform developed in collaboration with the SIRIO Institute on Ageing and renowned longevity researchers.

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Aenova Group: Aenova is one of Europe's largest pharmaceutical and nutraceutical CDMOs, headquartered in Germany with a comparable mix of softgel, tablet, and packaging services serving brand customers globally — the closest geographic and product-model peer to SIRIO Europe/Ayanda.
• Procaps Group: Procaps is an integrated CDMO and branded nutraceutical company based in Latin America offering softgel, gummy, and powder contract manufacturing with proprietary technologies — a closely aligned nutraceutical CDMO peer with similar proprietary delivery platform strategy.
• Hermes Arzneimittel: Hermes is a German pharmaceutical manufacturer with CDMO services in effervescents, tablets, and specialty oral dosage forms serving European and international brands — a regional direct peer in German pharma/nutra contract manufacturing.

Broad incumbents

• Catalent: Catalent is a global pharma and consumer health CDMO offering softgel (formerly Accucaps), gummy, and oral dose technologies with facilities worldwide, including Europe. It overlaps with SIRIO Europe in nutraceutical softgels but operates at much larger scale and across a broader pharma portfolio.
• Adare Pharmaceuticals: Adare Pharma Solutions is a US-based CDMO with technology platforms for taste-masking, modified release, and oral dosage forms serving pharma and consumer health customers — a broader incumbent with overlapping CDMO services and proprietary technology focus.
• Patheon (Thermo Fisher Scientific): Patheon, part of Thermo Fisher, is a global pharma CDMO with broad oral solid and softgel capabilities serving brand and generic customers — a broad incumbent competing with SIRIO Europe for premium contract manufacturing relationships.
• PCI Pharma Services: PCI Pharma Services is a global pharma CDMO providing clinical and commercial manufacturing, packaging, and supply chain services — a broader incumbent with adjacent CDMO capabilities serving regulated pharma and consumer health customers.

Regional players

• Bioplus Life Sciences: Bioplus is a Korean pharma CDMO offering oral solid, sterile injectable, and specialty manufacturing — a regional peer in Asian CDMO services with comparable technology platform focus but operating in different geographies.

Emerging players

• AB Biotics: AB Biotics is a Spanish biotech CDMO specializing in probiotics, synbiotics, and microbiome-based formulations with proprietary strain technology — a niche emerging player overlapping with SIRIO Europe's specialized ingredient and delivery format innovation.

Others

• Balchem Corporation: Balchem is a US ingredient supplier and contract manufacturer for human nutrition and pharma with mineral chelates and encapsulation expertise — an ecosystem partner (co-presenter at SIRIO's Innovation for the Future Summit) that competes for some CDMO business at the ingredient/formulation tier.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@SIRIOEurope
• LinkedInlinkedin.com/company/ayanda-

Compliance13 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ayanda